Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Fennec Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
FENC
Nasdaq
8731
https://fennecpharma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Fennec Pharmaceuticals Inc
Those who invested in Fennec Pharmaceuticals (NASDAQ:FENC) five years ago are up 136%
- Apr 9th, 2024 5:53 pm
Insider Sell: CEO Rosty Raykov Sells 88,583 Shares of Fennec Pharmaceuticals Inc (FENC)
- Apr 5th, 2024 11:00 pm
Chief Financial Officer Robert Andrade Sells 13,975 Shares of Fennec Pharmaceuticals Inc (FENC)
- Mar 27th, 2024 11:00 pm
Chief Financial Officer Robert Andrade Sells Shares of Fennec Pharmaceuticals Inc (FENC)
- Mar 26th, 2024 5:00 am
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q4 2023 Earnings Call Transcript
- Mar 22nd, 2024 1:49 pm
Q4 2023 Fennec Pharmaceuticals Inc Earnings Call
- Mar 22nd, 2024 9:04 am
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
- Mar 21st, 2024 10:00 am
Fennec (FENC) Signs Licensing Deal With Norgine, Stock Up
- Mar 19th, 2024 2:14 pm
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
- Mar 19th, 2024 10:01 am
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
- Mar 18th, 2024 1:00 am
Analysts Are Optimistic We'll See A Profit From Fennec Pharmaceuticals Inc. (NASDAQ:FENC)
- Mar 13th, 2024 3:14 pm
Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results
- Feb 29th, 2024 12:04 pm
FDA Issues Reminder of Non-Substitution of PEDMARKĀ® (sodium thiosulfate injection) for Pediatric Patients Receiving Cisplatin
- Feb 1st, 2024 10:55 am
Insider Sell: CFO Robert Andrade Sells 30,000 Shares of Fennec Pharmaceuticals Inc
- Jan 6th, 2024 8:01 am
With 31% stake, Fennec Pharmaceuticals Inc. (NASDAQ:FENC) seems to have captured hedge funds investors' interest
- Dec 6th, 2023 12:15 pm
Fennec Announces Incremental $5 Million Investment from Petrichor
- Dec 5th, 2023 10:55 am
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
- Nov 9th, 2023 9:50 pm
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
- Nov 9th, 2023 10:08 am
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q3 2023 Earnings Call Transcript
- Nov 7th, 2023 2:40 pm
Q3 2023 Fennec Pharmaceuticals Inc Earnings Call
- Nov 7th, 2023 7:10 am
Scroll